Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study

Background. Early intervention in prediabetes can prevent or delay the incidence of type 2 diabetes mellitus (T2DM). Traditional Chinese patent medicine (TCPM) is widely used in China to prevent T2DM. This study aims to evaluate the efficacy and safety of TCPMs for preventing T2DM. Method/Design. Th...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bing Pang, Yue-Ying Zhang, Hua-Jie Hu, Ye Sun, Ai-Mei Cao, Chun-Qian Lu, Wei-Hua Zhang, Qing Ni
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi Limited 2021
Materias:	Other systems of medicine RZ201-999
Acceso en línea:	https://doaj.org/article/b9cb0572d9cd459a8bd2cbdb45742fa0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b9cb0572d9cd459a8bd2cbdb45742fa0
record_format	dspace
spelling	oai:doaj.org-article:b9cb0572d9cd459a8bd2cbdb45742fa02021-11-22T01:10:28ZPrevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study1741-428810.1155/2021/6006802https://doaj.org/article/b9cb0572d9cd459a8bd2cbdb45742fa02021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/6006802https://doaj.org/toc/1741-4288Background. Early intervention in prediabetes can prevent or delay the incidence of type 2 diabetes mellitus (T2DM). Traditional Chinese patent medicine (TCPM) is widely used in China to prevent T2DM. This study aims to evaluate the efficacy and safety of TCPMs for preventing T2DM. Method/Design. This study is a multicenter, cohort study with two arms. A total of 600 participants will be recruited. The participants will be divided into either intervention or control groups according to their own desire, and the exposure factor is the application of TCPMs. All participants will be encouraged to lead a healthy lifestyle, and the intervention group also used TCPMs based on syndrome differentiation. Incident diabetes and normalization of blood glucose are indexes of end point. Safety assessments and adverse event monitoring will also be conducted. The treatment duration is set for 24 weeks, and we will follow-up for another 2 years. Discussion. This trial may provide initial evidence regarding the efficacy and safety of TCPMs plus lifestyle intervention (LI) compared to LI alone for preventing T2DM and provide a comprehensive intervention plans that choose suitable TCPMs for diabetes prevention according to syndrome differentiation. Trial Registration Number. Chinese Clinical Trial Registry ID: ChiCTR1900023541, registered on 1 Jun 2019. The version identifier is 2018121702.Bing PangYue-Ying ZhangHua-Jie HuYe SunAi-Mei CaoChun-Qian LuWei-Hua ZhangQing NiHindawi LimitedarticleOther systems of medicineRZ201-999ENEvidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Other systems of medicine RZ201-999
spellingShingle	Other systems of medicine RZ201-999 Bing Pang Yue-Ying Zhang Hua-Jie Hu Ye Sun Ai-Mei Cao Chun-Qian Lu Wei-Hua Zhang Qing Ni Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study
description	Background. Early intervention in prediabetes can prevent or delay the incidence of type 2 diabetes mellitus (T2DM). Traditional Chinese patent medicine (TCPM) is widely used in China to prevent T2DM. This study aims to evaluate the efficacy and safety of TCPMs for preventing T2DM. Method/Design. This study is a multicenter, cohort study with two arms. A total of 600 participants will be recruited. The participants will be divided into either intervention or control groups according to their own desire, and the exposure factor is the application of TCPMs. All participants will be encouraged to lead a healthy lifestyle, and the intervention group also used TCPMs based on syndrome differentiation. Incident diabetes and normalization of blood glucose are indexes of end point. Safety assessments and adverse event monitoring will also be conducted. The treatment duration is set for 24 weeks, and we will follow-up for another 2 years. Discussion. This trial may provide initial evidence regarding the efficacy and safety of TCPMs plus lifestyle intervention (LI) compared to LI alone for preventing T2DM and provide a comprehensive intervention plans that choose suitable TCPMs for diabetes prevention according to syndrome differentiation. Trial Registration Number. Chinese Clinical Trial Registry ID: ChiCTR1900023541, registered on 1 Jun 2019. The version identifier is 2018121702.
format	article
author	Bing Pang Yue-Ying Zhang Hua-Jie Hu Ye Sun Ai-Mei Cao Chun-Qian Lu Wei-Hua Zhang Qing Ni
author_facet	Bing Pang Yue-Ying Zhang Hua-Jie Hu Ye Sun Ai-Mei Cao Chun-Qian Lu Wei-Hua Zhang Qing Ni
author_sort	Bing Pang
title	Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study
title_short	Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study
title_full	Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study
title_fullStr	Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study
title_full_unstemmed	Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study
title_sort	prevention of diabetes in overweight/obese adults through traditional chinese patent medicine: study protocol for a prospective cohort study
publisher	Hindawi Limited
publishDate	2021
url	https://doaj.org/article/b9cb0572d9cd459a8bd2cbdb45742fa0
work_keys_str_mv	AT bingpang preventionofdiabetesinoverweightobeseadultsthroughtraditionalchinesepatentmedicinestudyprotocolforaprospectivecohortstudy AT yueyingzhang preventionofdiabetesinoverweightobeseadultsthroughtraditionalchinesepatentmedicinestudyprotocolforaprospectivecohortstudy AT huajiehu preventionofdiabetesinoverweightobeseadultsthroughtraditionalchinesepatentmedicinestudyprotocolforaprospectivecohortstudy AT yesun preventionofdiabetesinoverweightobeseadultsthroughtraditionalchinesepatentmedicinestudyprotocolforaprospectivecohortstudy AT aimeicao preventionofdiabetesinoverweightobeseadultsthroughtraditionalchinesepatentmedicinestudyprotocolforaprospectivecohortstudy AT chunqianlu preventionofdiabetesinoverweightobeseadultsthroughtraditionalchinesepatentmedicinestudyprotocolforaprospectivecohortstudy AT weihuazhang preventionofdiabetesinoverweightobeseadultsthroughtraditionalchinesepatentmedicinestudyprotocolforaprospectivecohortstudy AT qingni preventionofdiabetesinoverweightobeseadultsthroughtraditionalchinesepatentmedicinestudyprotocolforaprospectivecohortstudy
_version_	1718418364508930048

Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study

Ejemplares similares